vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $31.1M, roughly 1.9× LIFECORE BIOMEDICAL, INC. \DE\). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -32.1%, a 19.6% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -4.5%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $25.0K). Over the past eight quarters, CBAK Energy Technology, Inc.'s revenue compounded faster (-0.0% CAGR vs -0.1%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CBAT vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $31.1M |
| Net Profit | $-7.4M | $-10.0M |
| Gross Margin | 7.3% | 25.0% |
| Operating Margin | -13.6% | -9.9% |
| Net Margin | -12.5% | -32.1% |
| Revenue YoY | 131.8% | -4.5% |
| Net Profit YoY | -63.6% | -52.0% |
| EPS (diluted) | $-0.08 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | — | ||
| Q3 25 | $60.9M | $31.1M | ||
| Q2 25 | $40.5M | — | ||
| Q1 25 | $34.9M | $35.2M | ||
| Q4 24 | $25.4M | $32.6M | ||
| Q3 24 | $44.6M | $24.7M | ||
| Q2 24 | $47.8M | — | ||
| Q1 24 | $58.8M | $35.7M |
| Q4 25 | $-7.4M | — | ||
| Q3 25 | $2.7M | $-10.0M | ||
| Q2 25 | $-3.1M | — | ||
| Q1 25 | $-1.6M | $-14.8M | ||
| Q4 24 | $-4.5M | $-6.6M | ||
| Q3 24 | $17.6K | $-16.2M | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $9.8M | $15.6M |
| Q4 25 | 7.3% | — | ||
| Q3 25 | 8.0% | 25.0% | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 13.7% | 28.0% | ||
| Q4 24 | 13.1% | 34.0% | ||
| Q3 24 | 15.6% | 21.8% | ||
| Q2 24 | 26.6% | — | ||
| Q1 24 | 31.9% | 33.3% |
| Q4 25 | -13.6% | — | ||
| Q3 25 | -6.6% | -9.9% | ||
| Q2 25 | -8.7% | — | ||
| Q1 25 | -8.2% | -25.7% | ||
| Q4 24 | -26.0% | -6.0% | ||
| Q3 24 | -1.9% | -46.9% | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 17.4% | -2.5% |
| Q4 25 | -12.5% | — | ||
| Q3 25 | 4.4% | -32.1% | ||
| Q2 25 | -7.6% | — | ||
| Q1 25 | -4.5% | -42.0% | ||
| Q4 24 | -17.8% | -20.2% | ||
| Q3 24 | 0.0% | -65.7% | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | 16.7% | 43.8% |
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.03 | $-0.29 | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.02 | $-0.47 | ||
| Q4 24 | $-0.05 | $-0.25 | ||
| Q3 24 | $0.00 | $-0.53 | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.11 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $18.9M |
| Total DebtLower is stronger | $4.1M | $136.0M |
| Stockholders' EquityBook value | $112.7M | $-10.5M |
| Total Assets | $426.2M | $235.2M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | — | ||
| Q3 25 | $10.5M | $18.9M | ||
| Q2 25 | $45.7M | — | ||
| Q1 25 | $9.6M | $5.4M | ||
| Q4 24 | $11.0M | $9.5M | ||
| Q3 24 | $24.2M | — | ||
| Q2 24 | $44.1M | — | ||
| Q1 24 | $23.8M | — |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | $136.0M | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $4.1M | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $112.7M | — | ||
| Q3 25 | $121.4M | $-10.5M | ||
| Q2 25 | $118.2M | — | ||
| Q1 25 | $120.8M | $2.2M | ||
| Q4 24 | $121.7M | $15.4M | ||
| Q3 24 | $131.2M | $-3.9M | ||
| Q2 24 | $126.6M | — | ||
| Q1 24 | $120.9M | $17.7M |
| Q4 25 | $426.2M | — | ||
| Q3 25 | $363.9M | $235.2M | ||
| Q2 25 | $333.1M | — | ||
| Q1 25 | $311.5M | $237.7M | ||
| Q4 24 | $302.2M | $255.4M | ||
| Q3 24 | $293.5M | $246.8M | ||
| Q2 24 | $279.6M | — | ||
| Q1 24 | $286.5M | $246.2M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $1.8M |
| Free Cash FlowOCF − Capex | $16.1M | $25.0K |
| FCF MarginFCF / Revenue | 27.3% | 0.1% |
| Capex IntensityCapex / Revenue | 23.4% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | — | ||
| Q3 25 | $14.6M | $1.8M | ||
| Q2 25 | $13.8M | — | ||
| Q1 25 | $-9.6M | $1.2M | ||
| Q4 24 | $9.6M | $-6.1M | ||
| Q3 24 | $19.7M | $-613.0K | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $7.4M | $-1.4M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $6.0M | $25.0K | ||
| Q2 25 | $4.1M | — | ||
| Q1 25 | $-22.3M | $-4.3M | ||
| Q4 24 | $3.9M | $-8.6M | ||
| Q3 24 | $16.5M | $-4.0M | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $-454.0K | $-7.8M |
| Q4 25 | 27.3% | — | ||
| Q3 25 | 9.9% | 0.1% | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | -63.9% | -12.1% | ||
| Q4 24 | 15.5% | -26.3% | ||
| Q3 24 | 37.1% | -16.3% | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | -0.8% | -21.8% |
| Q4 25 | 23.4% | — | ||
| Q3 25 | 14.1% | 5.6% | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 36.3% | 15.5% | ||
| Q4 24 | 22.5% | 7.5% | ||
| Q3 24 | 7.0% | 13.9% | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 13.4% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
